Clinical trial
Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma
NCT00155272 · National Taiwan University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00155272 |
|---|---|
| Title | Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma |
| Official title | A Pilot Clinical and Mechanistic Study of Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma |
| Lead sponsor | National Taiwan University Hospital, Other |
| Collaborators | National Health Research Institutes, Taiwan |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hepatocellular Carcinoma |
| Intervention type | Drug |
| Interventions | Thalidomide |
| Enrollment | 19 |
| Start date | Mar 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 12, 2005 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: